Zeng Di, Wang Yaping, Chen Yi, Li Danyang, Li Guoli, Xiao Hanxianzhi, Hou Jiyin, Wang Ziling, Hu Ling, Wang Lu, Li Jing
Laboratory of Stem Cells and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical University, Chongqing, China.
Centre for Lipid Research & Key Laboratory of Molecular Biology for Infectious Diseases, Chongqing Medical University, Chongqing, China.
Front Oncol. 2021 Aug 16;11:720620. doi: 10.3389/fonc.2021.720620. eCollection 2021.
Oxidative stress induced by chemotherapeutic agents causes hepatotoxicity. 5-Fluorouracil (5-FU) has been found to have a variety of side effects, but its toxic effect on the liver and the mechanism are still unclear. Angelica polysaccharide (ASP), the main active ingredient of Dang Gui, has antioxidative stress effects. In this study, we investigated the antagonistic effects of ASP on 5-FU-induced injury in the mouse liver and human normal liver cell line MIHA and the possible mechanism. Our results show that ASP inhibited 5-FU-induced the decrease in Bcl-2 protein and the increase in Bax protein. ASP alleviated 5-FU-induced the increase in alanine aminotransferase (ALT), triglyceride (TG), and aspartate aminotransferase (AST) content; hepatic steatosis; and liver fibrosis. ASP restored 5-FU-induced swelling of mitochondria and the endoplasmic reticulum. 5-FU promoted the expression of Keap1 and increased the binding to NF-E2-related factor 2 (Nrf2) to reduce the nuclear translocation of Nrf2, thereby weakening the transcriptional activity of Nrf2 to inhibit the expression of HO-1; reducing the activity of GSH, SOD, and CAT to increase ROS content; and aggravating DNA damage (indicated by the increase in 8-OHdG). However, ASP reversed these reactions. In conclusion, ASP attenuated the 5-FU-induced Nrf2 pathway barrier to reduce oxidative stress injury and thereby inhibit the disorder of lipid anabolism and apoptosis. The study provides a new protectant for reducing the hepatic toxicity caused by 5-FU and a novel target for treating the liver injury.
化疗药物诱导的氧化应激会导致肝毒性。已发现5-氟尿嘧啶(5-FU)有多种副作用,但其对肝脏的毒性作用及机制仍不清楚。当归的主要活性成分当归多糖(ASP)具有抗氧化应激作用。在本研究中,我们探究了ASP对5-FU诱导的小鼠肝脏和人正常肝细胞系MIHA损伤的拮抗作用及其可能机制。我们的结果表明,ASP抑制了5-FU诱导的Bcl-2蛋白减少和Bax蛋白增加。ASP减轻了5-FU诱导的丙氨酸氨基转移酶(ALT)、甘油三酯(TG)和天冬氨酸氨基转移酶(AST)含量增加;肝脂肪变性;以及肝纤维化。ASP恢复了5-FU诱导的线粒体和内质网肿胀。5-FU促进Keap1的表达并增加其与核因子E2相关因子2(Nrf2)的结合,从而减少Nrf2的核转位,进而削弱Nrf2的转录活性以抑制血红素加氧酶-1(HO-1)的表达;降低谷胱甘肽(GSH)、超氧化物歧化酶(SOD)和过氧化氢酶(CAT)的活性以增加活性氧(ROS)含量;并加重DNA损伤(以8-羟基脱氧鸟苷(8-OHdG)增加表示)。然而,ASP逆转了这些反应。总之,ASP减轻了5-FU诱导的Nrf2通路障碍,以减少氧化应激损伤,从而抑制脂质合成代谢紊乱和细胞凋亡。该研究为减轻5-FU所致肝毒性提供了一种新的保护剂,并为治疗肝损伤提供了一个新靶点。